Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015

Don Des Jarlais, Courtney Mcknight, Jonathan Feelemyer, Kamyar Arasteh, Susan Tross, Aimee N.C. Campbell, Hannah L.F. Cooper, David C. Perlman

Research output: Contribution to journalArticle

Abstract

Background: We examined whether sex disparities (heterosexual male:female) in HIV infection continue to persist at the “end of the HIV epidemic” among persons who inject drugs (PWID) in New York City (NYC). An “end of the epidemic” was operationally defined as 1) prevalence of untreated HIV infection <5%, and 2) estimated HIV incidence <0.5/100 person-years. Methods: PWID were recruited from persons entering substance use treatment programs at Mount Sinai Beth Israel in 2001–2005 and 2011–2015. A structured interview was administered, and HIV and HSV-2 testing was conducted. Incidence was estimated using newly diagnosed cases of HIV. Disparity analyses compared prevalence of HIV, of untreated HIV, HIV risk behaviors, and estimated HIV incidence. Results: By 2011–2015, both heterosexual male and female PWID met the two criteria for an “end of the epidemic,” and there were no significant differences in the prevalence of untreated HIV infection. A large sex difference remained in estimated HIV incidence. In 2013–2015, estimated HIV incidence was 2.8/10,000 PY for males and 7.1/10,000 PY for females. Females had greater risk for HIV on several factors. Conclusion: While NYC has reached an “end of the epidemic” for both heterosexual male and female PWID, sex disparities persist, particularly differences in HIV incidence. Eliminating the sex disparities may require a greater focus on factors associated with sexual transmission.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalDrug and Alcohol Dependence
Volume185
DOIs
StatePublished - Apr 1 2018

Fingerprint

Heterosexuality
HIV Infections
HIV
Pharmaceutical Preparations
Incidence
HIV-2
Testing
Human Herpesvirus 2
Israel
Risk-Taking
Sex Characteristics
Interviews

Keywords

  • HIV
  • Injection drug use
  • New York city
  • Sex/Gender disparities

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Heterosexual male and female disparities in HIV infection at the end of an epidemic : HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015. / Des Jarlais, Don; Mcknight, Courtney; Feelemyer, Jonathan; Arasteh, Kamyar; Tross, Susan; Campbell, Aimee N.C.; Cooper, Hannah L.F.; Perlman, David C.

In: Drug and Alcohol Dependence, Vol. 185, 01.04.2018, p. 391-397.

Research output: Contribution to journalArticle

@article{6231b36192d642c1a120e68210702ff8,
title = "Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015",
abstract = "Background: We examined whether sex disparities (heterosexual male:female) in HIV infection continue to persist at the “end of the HIV epidemic” among persons who inject drugs (PWID) in New York City (NYC). An “end of the epidemic” was operationally defined as 1) prevalence of untreated HIV infection <5{\%}, and 2) estimated HIV incidence <0.5/100 person-years. Methods: PWID were recruited from persons entering substance use treatment programs at Mount Sinai Beth Israel in 2001–2005 and 2011–2015. A structured interview was administered, and HIV and HSV-2 testing was conducted. Incidence was estimated using newly diagnosed cases of HIV. Disparity analyses compared prevalence of HIV, of untreated HIV, HIV risk behaviors, and estimated HIV incidence. Results: By 2011–2015, both heterosexual male and female PWID met the two criteria for an “end of the epidemic,” and there were no significant differences in the prevalence of untreated HIV infection. A large sex difference remained in estimated HIV incidence. In 2013–2015, estimated HIV incidence was 2.8/10,000 PY for males and 7.1/10,000 PY for females. Females had greater risk for HIV on several factors. Conclusion: While NYC has reached an “end of the epidemic” for both heterosexual male and female PWID, sex disparities persist, particularly differences in HIV incidence. Eliminating the sex disparities may require a greater focus on factors associated with sexual transmission.",
keywords = "HIV, Injection drug use, New York city, Sex/Gender disparities",
author = "{Des Jarlais}, Don and Courtney Mcknight and Jonathan Feelemyer and Kamyar Arasteh and Susan Tross and Campbell, {Aimee N.C.} and Cooper, {Hannah L.F.} and Perlman, {David C.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.drugalcdep.2017.12.039",
language = "English (US)",
volume = "185",
pages = "391--397",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Heterosexual male and female disparities in HIV infection at the end of an epidemic

T2 - HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015

AU - Des Jarlais, Don

AU - Mcknight, Courtney

AU - Feelemyer, Jonathan

AU - Arasteh, Kamyar

AU - Tross, Susan

AU - Campbell, Aimee N.C.

AU - Cooper, Hannah L.F.

AU - Perlman, David C.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: We examined whether sex disparities (heterosexual male:female) in HIV infection continue to persist at the “end of the HIV epidemic” among persons who inject drugs (PWID) in New York City (NYC). An “end of the epidemic” was operationally defined as 1) prevalence of untreated HIV infection <5%, and 2) estimated HIV incidence <0.5/100 person-years. Methods: PWID were recruited from persons entering substance use treatment programs at Mount Sinai Beth Israel in 2001–2005 and 2011–2015. A structured interview was administered, and HIV and HSV-2 testing was conducted. Incidence was estimated using newly diagnosed cases of HIV. Disparity analyses compared prevalence of HIV, of untreated HIV, HIV risk behaviors, and estimated HIV incidence. Results: By 2011–2015, both heterosexual male and female PWID met the two criteria for an “end of the epidemic,” and there were no significant differences in the prevalence of untreated HIV infection. A large sex difference remained in estimated HIV incidence. In 2013–2015, estimated HIV incidence was 2.8/10,000 PY for males and 7.1/10,000 PY for females. Females had greater risk for HIV on several factors. Conclusion: While NYC has reached an “end of the epidemic” for both heterosexual male and female PWID, sex disparities persist, particularly differences in HIV incidence. Eliminating the sex disparities may require a greater focus on factors associated with sexual transmission.

AB - Background: We examined whether sex disparities (heterosexual male:female) in HIV infection continue to persist at the “end of the HIV epidemic” among persons who inject drugs (PWID) in New York City (NYC). An “end of the epidemic” was operationally defined as 1) prevalence of untreated HIV infection <5%, and 2) estimated HIV incidence <0.5/100 person-years. Methods: PWID were recruited from persons entering substance use treatment programs at Mount Sinai Beth Israel in 2001–2005 and 2011–2015. A structured interview was administered, and HIV and HSV-2 testing was conducted. Incidence was estimated using newly diagnosed cases of HIV. Disparity analyses compared prevalence of HIV, of untreated HIV, HIV risk behaviors, and estimated HIV incidence. Results: By 2011–2015, both heterosexual male and female PWID met the two criteria for an “end of the epidemic,” and there were no significant differences in the prevalence of untreated HIV infection. A large sex difference remained in estimated HIV incidence. In 2013–2015, estimated HIV incidence was 2.8/10,000 PY for males and 7.1/10,000 PY for females. Females had greater risk for HIV on several factors. Conclusion: While NYC has reached an “end of the epidemic” for both heterosexual male and female PWID, sex disparities persist, particularly differences in HIV incidence. Eliminating the sex disparities may require a greater focus on factors associated with sexual transmission.

KW - HIV

KW - Injection drug use

KW - New York city

KW - Sex/Gender disparities

UR - http://www.scopus.com/inward/record.url?scp=85043473923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043473923&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2017.12.039

DO - 10.1016/j.drugalcdep.2017.12.039

M3 - Article

VL - 185

SP - 391

EP - 397

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -